The Impact of Cocoa Flavanols on Cardiovascular Health

Phytotherapy Research

Volumn 30, Issue 10, 2016, Pages 1641-1657

  Vlachojannis, Julia ^a   Erne, Paul ^b   Zimmermann, Benno ^c,d   Chrubasik Hausmann, Sigrun ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BONN   (Germany)

^d Institut Prof Dr Georg Kurz GmbH   (Germany)

Author keywords

blood glucose; blood lipids; blood pressure; chocolate; cocoa; flavanols; flow mediated vasodilatation

Indexed keywords

EPICATECHIN; FLAVANOL DERIVATIVE; FLAVONOID;

ARTICLE; BLOOD PRESSURE; CACAO; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR HEALTH; CORONARY ARTERY DILATATION; DIET THERAPY; DRUG EFFICACY; DRUG IDENTIFICATION; FOOD INTAKE; HUMAN; OUTCOME ASSESSMENT; SYSTEMATIC REVIEW; ANALYSIS; CARDIOVASCULAR DISEASES; CHEMISTRY; CHOCOLATE; DRUG EFFECTS;

BLOOD PRESSURE; CACAO; CARDIOVASCULAR DISEASES; CHOCOLATE; FLAVONOIDS; HUMANS;

EID: 84978148072     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5665     Document Type: Article

References (116)

1. Al-Faris NA. 2008. Short-term consumption of a dark chocolate containing flavanols is followed by a significant decrease in normotensive population. Pak J Nutr 7: 773–781.
2. Allen RR, Carson L, Kwik-Uribe C, Evans EM, Erdman JW Jr. 2008. Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol. J Nutr 138: 725–731.
3. Allgrove J, Farrell E, Gleeson M, Williamson G, Cooper K. 2011. Regular dark chocolate consumption's reduction of oxidative stress and increase of free-fatty-acid mobilization in response to prolonged cycling. Int J Sport Nutr Exerc Metab 21: 113–123.
4. Almoosawi S, Fyfe L, Ho C, Al-Dujaili E. 2010. The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects. Br J Nutr 103: 842–850.
5. Arranz S, Valderas-Martinez P, Chiva-Blanch G, et al. 2013. Cardioprotective effects of cocoa: clinical evidence from randomized clinical intervention trials in humans. Mol Nutr Food Res 57: 936–947.
6. Arts IC, Hollman PC, Kromhout D. 1999. Chocolate as a source of tea flavonoids. Lancet 354(9177): 488.
7. Baba S, Natsume M, Yasuda A, et al. 2007a. Plasma LDL and HDL cholesterol and oxidized LDL concentrations are altered in normo- and hypercholesterolemic humans after intake of different levels of cocoa powder. J Nutr 137: 1436–1441.
8. Baba S, Osakabe N, Kato Y, et al. 2007b. Continuous intake of polyphenolic compounds containing cocoa powder reduces LDL oxidative susceptibility and has beneficial effects on plasma HDL-cholesterol concentrations in humans. Am J Clin Nutr 85: 709–717.
9. Balzer J, Rassaf T, Heiss C, et al. 2008. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol 51: 2141–2149.
10. Berends LM, van der Velpen V, Cassidy A. 2015. Flavan-3-ols, theobromine, and the effects of cocoa and chocolate on cardiometabolic risk factors. Curr Opin Lipidol 26: 10–19.
11. Berry NM, Davison K, Coates AM, Buckley JD, Howe PR. 2010. Impact of cocoa flavanol consumption on blood pressure responsiveness to exercise. Br J Nutr 103: 1480–1484.
12. van den Bogaard B, Draijer R, Westerhof BE, van den Meiracker AH, van Montfrans GA, van den Born BJ. 2010. Effects on peripheral and central blood pressure of cocoa with natural or high-dose theobromine: a randomized, double-blind crossover trial. Hypertension 56: 839–846.
13. Brillo E, Di Renzo GC. 2015. Chocolate and other cocoa products: effects on human reproduction and pregnancy. J Agric Food Chem 63: 9927–9935.
14. Buitrago-Lopez A, Sanderson J, Johnson L, et al. 2011. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ 343: d4488.
15. Chrubasik-Hausmann S, Vlachojannis C, Zimmermann BF. 2014a. Proanthocyanin content in cranberry CE medicinal products. Phytother Res 28: 1612–1614.
16. Chrubasik-Hausmann S, Vlachojannis C, Zimmermann B. 2014b. Pomegranate juice and prostate cancer: importance of the characterisation of the active principle. Phytother Res 28: 1676–1678.
17. Cifuentes-Gomez T, Rodriguez-Mateos A, Gonzalez-Salvador I, Alañon ME, Spencer JP. 2015. Factors affecting the absorption, metabolism, and excretion of cocoa flavanols in humans. J Agric Food Chem 63: 7615–7623.
18. Corti R, Flammer AJ, Hollenberg NK, Lüscher TF. 2009. Cocoa and cardiovascular health. Circulation 119: 1433–1441.
19. Crews WD Jr, Harrison DW, Wright JW. 2008. A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr 87: 872–880.
20. Damm I, Enger E, Chrubasik-Hausmann S, Schieber A, Zimmermann BF. 2016. Comprehensive analysis of secondary metabolites in cocoa products using pressurized liquid extraction and ultra high-performance liquid chromatography. J Sep Sci: in press.
21. Davison K, Coates AM, Buckley JD, Howe PR. 2008. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes (Lond) 32: 1289–1296.
22. Davison K, Berry NM, Misan G, Coates AM, Buckley JD, Howe PR. 2010. Dose-related effects of flavanol-rich cocoa on blood pressure. J Hum Hypertens 24: 568–576.
23. Davidson E, Vlachojannis J, Cameron M, Chrubasik S. 2013. Best available evidence in Cochrane reviews on herbal medicine? Evid Based Complement Alternat Med 2013: 163412.
24. Davidson E, Zimmermann BF, Jungfer E, Chrubasik-Hausmann S. 2014. Prevention of urinary tract infections with vaccinium products. Phytother Res 28: 465–470.
25. Desch S, Kobler D, Schmidt J, et al. 2010a. Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens 23: 694–700.
26. Desch S, Schmidt J, Kobler D, et al. 2010b. Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens 23: 97–103.
27. Di Renzo GC, Brillo E, Romanelli M, et al. 2012. Potential effects of chocolate on human pregnancy: a randomized controlled trial. J Matern Fetal Neonatal Med 25: 1860–1867.
28. Dower JI, Geleijnse JM, Gijsbers L, Zock PL, Kromhout D, Hollman PC. 2015a. Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial. Am J Clin Nutr 101: 914–921.
29. Dower JI, Geleijnse JM, Gijsbers L, Schalkwijk C, Kromhout D, Hollman PC. 2015b. Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre)hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial. J Nutr 145: 1459–1463.
30. EFSA. 2012. Scientific opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA J 10: 2809.
31. Ellinger S, Reusch A, Stehle P, Helfrich HP. 2012. Epicatechin ingested via cocoa products reduces blood pressure in humans: a nonlinear regression model with a Bayesian approach. Am J Clin Nutr 95: 1365–1377.
32. Engler MB, Engler MM, Chen CY, et al. 2004. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23: 197–204.
33. Esser D, Mars M, Oosterink E, Stalmach A, Müller M, Afman LA. 2014. Dark chocolate consumption improves leukocyte adhesion factors and vascular function in overweight men. FASEB J 28: 1464–1473.
34. Faridi Z, Njike VY, Dutta S, Ali A, Katz DL. 2008. Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr 88: 58–63.
35. Farouque HM, Leung M, Hope SA, et al. 2006. Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin Sci (Lond) 111: 71–80.
36. Ferrari CK, Percário S, Silva JC, da Silva Torres EA. 2016. An apple plus a nut a day keeps the doctors away: antioxidant capacity OF foods and THEIR health benefits. Curr Pharm Des 22: 189-95.
37. Fisher ND, Hughes M, Gerhard-Herman M, Hollenberg NK. 2003. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. J Hypertens 21: 2281–2286.
38. Flammer AJ, Sudano I, Wolfrum M, et al. 2012. Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. Eur Heart J 33: 2172–2180.
39. Fraga CG, Actis-Goretta L, Ottaviani JI, et al. 2005. Regular consumption of a flavanol-rich chocolate can improve oxidant stress in young soccer players. Clin Dev Immunol 12: 11–17.
40. Franco R, Oñatibia-Astibia A, Martínez-Pinilla E. 2013. Health benefits of methylxanthines in cacao and chocolate. Nutrients 5: 4159–4173.
41. Grassi D, Necozione S, Lippi C, et al. 2005a. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46: 398–405.
42. Grassi D, Lippi C, Necozione S, Desideri G, Ferri C. 2005b. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 81: 611–614.
43. Grassi D, Desideri G, Necozione S, et al. 2008. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr 138: 1671–1676.
44. Grassi D, Desideri G, Necozione S, et al. 2012. Protective effects of flavanol-rich dark chocolate on endothelial function and wave reflection during acute hyperglycemia. Hypertension 60: 827–832.
45. Grassi D, Desideri G, Ferri C. 2013. Protective effects of dark chocolate on endothelial function and diabetes. Curr Opin Clin Nutr Metab Care 16: 662–668.
46. Grassi D, Desideri G, Necozione S, et al. 2015. Cocoa consumption dose-dependently improves flow-mediated dilation and arterial stiffness decreasing blood pressure in healthy individuals. J Hypertens 33: 294–303.
47. Hammer A, Koppensteiner R, Steiner S, et al. 2015. Dark chocolate and vascular function in patients with peripheral artery disease: a randomized, controlled cross-over trial. Clin Hemorheol Microcirc 59: 145–153.
48. Heiss C, Dejam A, Kleinbongard P, Schewe T, Sies H, Kelm M. 2003. Vascular effects of cocoa rich in flavan-3-ols. JAMA 290: 1030–1031.
49. Heiss C, Kleinbongard P, Dejam A, et al. 2005. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 46: 1276–1283.
50. Heiss C, Finis D, Kleinbongard P, et al. 2007. Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J Cardiovasc Pharmacol 49: 74–80.
51. Heiss C, Jahn S, Taylor M, et al. 2010. Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. J Am Coll Cardiol 56: 218–224.
52. Heiss C, Sansone R, Karimi H, et al. 2015. Impact of cocoa flavanol intake on age-dependent vascular stiffness in healthy men: a randomized, controlled, double-masked trial. Age (Dordr) 37: 9794.
53. Hermann F, Spieker LE, Ruschitzka F, et al. 2006. Dark chocolate improves endothelial and platelet function. Heart 92: 119–120.
54. Hooper L, Kay C, Abdelhamid A, et al. 2012. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 95: 740–751.
55. Horn P, Cortese-Krott MM, Amabile N, et al. 2012. Circulating microparticles carry a functional endothelial nitric oxide synthase that is decreased in patients with endothelial dysfunction. J Am Heart Assoc 2: e003764.
56. Horn P, Amabile N, Angeli FS, et al. 2014. Dietary flavanol intervention lowers the levels of endothelial microparticles in coronary artery disease patients. Br J Nutr 111: 1245–1252.
57. Jia L, Liu X, Bai YY, et al. 2010. Short-term effect of cocoa product consumption on lipid profile: a meta-analysis of randomized controlled trials. Am J Clin Nutr 92: 218–225.
58. Ioannone F, Di Mattia CD, De Gregorio M, Sergi M, Serafini M, Sacchetti G. 2015. Flavanols, proanthocyanidins and antioxidant activity changes during cocoa (Theobroma cacao L.) roasting as affected by temperature and time of processing. Food Chem 174: 256–262.
59. Kim J, Kim J, Shim J, Lee CY, Lee KW, Lee HJ. 2014. Cocoa phytochemicals: recent advances in molecular mechanisms on health. Crit Rev Food Sci Nutr 54: 1458–1472.
60. Kurlandsky S, Stote K. 2006. Cardioprotective effects of chocolate and almond consumption in healthy women. Nutr Res 26: 509–516.
61. Kwok CS, Boekholdt SM, Lentjes MA, et al. 2015. Habitual chocolate consumption and risk of cardiovascular disease among healthy men and women. Heart 101: 1279–1287.
62. Langer S, Marshall LJ, Day AJ, Morgan MR. 2011. Flavanols and methylxanthines in commercially available dark chocolate: a study of the correlation with nonfat cocoa solids. J Agric Food Chem 59: 8435–8441.
63. Martínez-López S, Sarriá B, Sierra-Cinos JL, Goya L, Mateos R, Bravo L. 2014. Realistic intake of a flavanol-rich soluble cocoa product increases HDL-cholesterol without inducing anthropometric changes in healthy and moderately hypercholesterolemic subjects. Food Funct 5: 364–374.
64. Mellor DD, Sathyapalan T, Kilpatrick ES, Beckett S, Atkin SL. 2010. High-cocoa polyphenol-rich chocolate improves HDL cholesterol in Type 2 diabetes patients. Diabet Med 27: 1318–1321.
65. Meng CC, Jalil AM, Ismail A. 2009. Phenolic and theobromine contents of commercial dark, milk and white chocolates on the Malaysian market. Molecules 14: 200–209.
66. Miller KB, Stuart DA, Smith NL, et al. 2006. Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J Agric Food Chem 54: 4062–4068.
67. Mogollon JA, Bujold E, Lemieux S, et al. 2013. Blood pressure and endothelial function in healthy, pregnant women after acute and daily consumption of flavanol-rich chocolate: a pilot, randomized controlled trial. Nutr J 12: 41.
68. Monagas M, Khan N, Andres-Lacueva C, et al. 2009. Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am J Clin Nutr 90: 1144–1150.
69. Monahan KD, Feehan RP, Kunselman AR, Preston AG, Miller DL, Lott ME. 2011. Dose-dependent increases in flow-mediated dilation following acute cocoa ingestion in healthy older adults. J Appl Physiol (1985) 111: 1568–1574.
70. Muniyappa R, Hall G, Kolodziej TL, Karne RJ, Crandon SK, Quon MJ. 2008. Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am J Clin Nutr 88: 1685–1696.
71. Murphy KJ, Chronopoulos AK, Singh I, et al. 2003. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr 77: 1466–1473.
72. Njike VY, Faridi Z, Shuval K, et al. 2011. Effects of sugar-sweetened and sugar-free cocoa on endothelial function in overweight adults. Int J Cardiol 149: 83–88.
73. Oracz J, Zyzelewicz D, Nebesny E. 2015. The content of polyphenolic compounds in cocoa beans (Theobroma cacao L.), depending on variety, growing region, and processing operations: a review. Crit Rev Food Sci Nutr 55: 1176–1192.
74. Ottaviani JI, Momma TY, Heiss C, Kwik-Uribe C, Schroeter H, Keen CL. 2011. The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radic Biol Med 50: 237–244.
75. Ottaviani JI, Kwik-Uribe C, Keen CL, Schroeter H. 2012. Intake of dietary procyanidins does not contribute to the pool of circulating flavanols in humans. Am J Clin Nutr 95: 851–858.
76. Peluso I, Palmery M, Serafini M. 2015. Effect of cocoa products and flavanols on platelet aggregation in humans: a systematic review. Food Funct 6: 2128–2134.
77. Pereira T, Maldonado J, Laranjeiro M, et al. 2014. Central arterial hemodynamic effects of dark chocolate ingestion in young healthy people: a randomized and controlled trial. Cardiol Res Pract 2014: 945951.
78. Polagruto JA, Wang-Polagruto JF, Braun MM, Lee L, Kwik-Uribe C, Keen CL. 2006. Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein cholesterol levels. J Am Diet Assoc 106: 1804–1813.
79. Ried K, Frank OR, Stocks NP. 2009. Dark chocolate or tomato extract for prehypertension: a randomised controlled trial. BMC Complement Altern Med 9: 22.
80. Ried K, Sullivan TR, Fakler P, Frank OR, Stocks NP. 2012. Effect of cocoa on blood pressure. Cochrane Database Syst Rev 8: CD008893.
81. Rodriguez-Mateos A, Cifuentes-Gomez T, Gonzalez-Salvador I, et al. 2015. Influence of age on the absorption, metabolism, and excretion of cocoa flavanols in healthy subjects. Mol Nutr Food Res 59: 1504–1512.
82. Rull G, Mohd-Zain ZN, Shiel J, et al. 2015. Effects of high flavanol dark chocolate on cardiovascular function and platelet aggregation. Vascul Pharmacol 71: 70–78.
83. Sansone R, Rodriguez-Mateos A, Heuel J, et al. 2015. Cocoa flavanol intake improves endothelial function and Framingham Risk Score in healthy men and women: a randomised, controlled, double-masked trial: the Flaviola Health Study. Br J Nutr 114: 1246–1255.
84. Sarriá B, Martínez-López S, Sierra-Cinos JL, et al. 2015. Effects of bioactive constituents in functional cocoa products on cardiovascular health in humans. Food Chem 174: 214–218.
85. Sathyapalan T, Beckett S, Rigby AS, Mellor DD, Atkin SL. 2010. High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutr J 9: 55.
86. Shiina Y, Funabashi N, Lee K, et al. 2009. Acute effect of oral flavonoid-rich dark chocolate intake on coronary circulation, as compared with non-flavonoid white chocolate, by transthoracic Doppler echocardiography in healthy adults. Int J Cardiol 131: 424–429.
87. Shively CA, Tarka SM Jr. 1984. Methylxanthine composition and consumption patterns of cocoa and chocolate products. Prog Clin Biol Res 158: 149–178.
88. Schnorr O, Brossette T, Momma TY, et al. 2008. Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch Biochem Biophys 476: 211–215.
89. Scholey A, Owen L. 2013. Effects of chocolate on cognitive function and mood: a systematic review. Nutr Rev 71: 665–681.
90. Schroeter H, Heiss C, Balzer J, et al. 2006. (−)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 103: 1024–1029.
91. Shrime MG, Bauer SR, McDonald AC, Chowdhury NH, Coltart CE, Ding EL. 2011. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr 141: 1982–1988.
92. Sorond FA, Lipsitz LA, Hollenberg NK, Fisher ND. 2008. Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatr Dis Treat 4: 433–440.
93. Sudano I, Flammer AJ, Roas S, et al. 2012. Cocoa, blood pressure, and vascular function. Curr Hypertens Rep 14: 79–84.
94. Taubert D, Berkels R, Roesen R, Klaus W. 2003. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. JAMA 290: 1029–1030.
95. Taubert D, Roesen R, Lehmann C, Jung N, Schömig E. 2007. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 298: 49–60.
96. Tokede OA, Gaziano JM, Djoussé L. 2011. Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis. Eur J Clin Nutr 65: 879–886.
97. Torres-Moreno M, Torrescasana E, Salas-Salvadó J, Blanch C. 2015. Nutritional composition and fatty acids profile in cocoa beans and chocolates with different geographical origin and processing conditions. Food Chem 166: 125–132.
98. Tzounis X, Rodriguez-Mateos A, Vulevic J, Gibson GR, Kwik-Uribe C, Spencer JP. 2011. Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 93: 62–72.
99. Verna R. 2013. The history and science of chocolate. Malays J Pathol 35: 111–121.
100. Vertuani S, Scalambra E, Vittorio T, et al. 2014. Evaluation of antiradical activity of different cocoa and chocolate products: relation with lipid and protein composition. J Med Food 17: 512–516.
101. Vlachojannis JE, Cameron M, Chrubasik S. 2009. A systematic review on the effectiveness of willow bark for musculoskeletal pain. Phytother Res 23: 897–900.
102. Vlachojannis JE, Cameron M, Chrubasik S. 2010a. A systematic review on the sambuci fructus effect and efficacy profiles. Phytother Res 24: 1–8.
103. Vlachojannis JE, Cameron M, Chrubasik S. 2010b. Medicinal use of potato-derived products: a systematic review. Phytother Res 24: 159–162.
104. Vlachojannis C, Winsauer H, Chrubasik S. 2013. Effectiveness and safety of a mouthwash containing essential oil ingredients. Phytother Res 27: 685–691.
105. Vlachojannis C, Zimmermann BF, Chrubasik-Hausmann S. 2015a. Efficacy and safety of pomegranate medicinal products for cancer. Evid Based Complement Alternat Med 2015: 258598.
106. Vlachojannis C, Erne P, Schoenenberger A, Chrubasik-Hausmann S. 2015b. A critical evaluation of the clinical evidence of pomegranate preparations in the prevention and treatment of cardiovascular diseases. Phytotherapy Res 29: 501–508.
107. Vlachojannis C, Al-Ahmad A, Hellwig E, Chrubasik-Hausmann S. 2016. Listerine® and essential oil mouthwashes: an update on the efficacy and safety. Phytother Res 30: in press:.
108. Vlachopoulos C, Aznaouridis K, Alexopoulos N, Economou E, Andreadou I, Stefanadis C. 2005. Effect of dark chocolate on arterial function in healthy individuals. Am J Hypertens 18: 785–791.
109. Vogiatzoglou A, Mulligan AA, Luben RN, et al. 2014. Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union. Br J Nutr 111: 1463–1473.
110. Wan Y, Vinson JA, Etherton TD, Proch J, Lazarus SA, Kris-Etherton PM. 2001. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. Am J Clin Nutr 74: 596–602.
111. Wang X, Ouyang YY, Liu J, Zhao G. 2014. Flavonoid intake and risk of CVD: a systematic review and meta-analysis of prospective cohort studies. Br J Nutr 111: 1–11.
112. Wang-Polagruto JF, Villablanca AC, Polagruto JA, et al. 2006. Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women. J Cardiovasc Pharmacol 47(Suppl 2): S177–S186.
113. Warren RE, Marshall T, Padfield PL, Chrubasik S. 2010. Variability of office, 24-hour ambulatory, and self-monitored blood pressure measurements. Br J Gen Pract 60(578): 675–680.
114. West SG, McIntyre MD, Piotrowski MJ, et al. 2014. Effects of dark chocolate and cocoa consumption on endothelial function and arterial stiffness in overweight adults. Br J Nutr 111: 653–661.
115. Wollgast J. 2004. The contents and effects of polyphenols in chocolate. Thesis. University of Giessen. http://geb.uni-giessen.de/geb/volltexte/2005/2239/pdf/WollgastJan-2005-06-10.pdf
116. Zhang Z, Xu G, Liu X. 2013. Chocolate intake reduces risk of cardiovascular disease: evidence from 10 observational studies. Int J Cardiol 168: 5448–5450.